TGF-β limits IL-33 production and promotes the resolution of colitis through regulation of macrophage function

European Journal of Immunology

Volumn 41, Issue 7, 2011, Pages 2000-2009

  Rani, Reena ^a   Smulian, Alan G ^b   Greaves, David R ^c   Hogan, Simon P ^a   Herbert, De'Broski R ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Inflammation; Intestine; M symbol s

Indexed keywords

CD68 ANTIGEN; DEXTRAN SULFATE; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 33; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL REGENERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; GOBLET CELL; GRANULOCYTE; HISTOPATHOLOGY; IMMUNE DEFICIENCY; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LETHALITY; MACROPHAGE FUNCTION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; TRANSGENE; TRANSGENIC MOUSE; ULCERATIVE COLITIS;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BLOTTING, SOUTHERN; COLITIS; COLITIS, ULCERATIVE; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; IMMUNOGLOBULIN E; INTERLEUKINS; MACROPHAGES; MICE; MICE, TRANSGENIC; PROMOTER REGIONS, GENETIC; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA;

EID: 79959713114     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201041135     Document Type: Article

References (56)

1. Ding, L. A., Li, J. S., Li, Y. S., Zhu, N. T., Liu, F. N. and Tan, L., Intestinal barrier damage caused by trauma and lipopolysaccharide. World J. Gastroenterol. 2004. 10: 2373-2378.
2. Xavier, R. J. and Podolsky, D. K., Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007. 448: 427-434.
3. Wirtz, S., Neufert, C., Weigmann, B. and Neurath, M. F., Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2007. 2: 541-546.
4. Monteleone, G., Caruso, R., Fina, D., Peluso, I., Gioia, V., Stolfi, C., Fantini, M. C. et al., Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21. Gut 2006. 55: 1774-1780.
5. Gordon, J. N., Pickard, K. M., Di Sabatino, A., Prothero, J. D., Pender, S. L., Goggin, P. M. and MacDonald, T. T., Matrix metalloproteinase-3 production by gut IgG plasma cells in chronic inflammatory bowel disease. Inflamm. Bowel Dis. 2008. 14: 195-203.
6. Brown, S. J. and Mayer, L., The immune response in inflammatory bowel disease. Am. J. Gastroenterol. 2007. 102: 2058-2069.
7. Dieleman, L. A., Ridwan, B. U., Tennyson, G. S., Beagley, K. W., Bucy, R. P. and Elson, C. O., Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994. 107: 1643-1652.
8. + T cells. J. Immunol. 2004. 173: 6526-6531.
9. Hausmann, M., Obermeier, F., Schreiter, K., Spottl, T., Falk, W., Scholmerich, J., Herfarth, H. et al., Cathepsin D is up-regulated in inflammatory bowel disease macrophages. Clin. Exp. Immunol. 2004. 136: 157-167.
10. Ghia, J. E., Galeazzi, F., Ford, D. C., Hogaboam, C. M., Vallance, B. A. and Collins, S., Role of M-CSF-dependent macrophages in colitis is driven by the nature of the inflammatory stimulus. Am. J. Physiol. Gastrointest. Liver Physiol. 2008. 294: G770-G777.
11. Kamada, N., Hisamatsu, T., Okamoto, S., Chinen, H., Kobayashi, T., Sato, T., Sakuraba, A. et al., Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-γ axis. J. Clin. Invest. 2008. 118: 2269-2280.
12. Platt, A. M., Bain, C. C., Bordon, Y., Sester, D. P. and Mowat, A. M., An independent subset of TLR expressing CCR2-dependent macrophages promotes colonic inflammation. J. Immunol. 2010. 184: 6843-6854.
13. Pull, S. L., Doherty, J. M., Mills, J. C., Gordon, J. I. and Stappenbeck, T. S., Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc. Natl. Acad. Sci. USA 2005. 102: 99-104.
14. Qualls, J. E., Kaplan, A. M., van Rooijen, N. and Cohen, D. A., Suppression of experimental colitis by intestinal mononuclear phagocytes. J. Leukoc. Biol. 2006. 80: 802-815.
15. Okamoto, R. and Watanabe, M., Cellular and molecular mechanisms of the epithelial repair in IBD. Dig. Dis. Sci. 2005. 50: S34-S38.
16. Smith, P. D., Ochsenbauer-Jambor, C. and Smythies, L. E., Intestinal macrophages: unique effector cells of the innate immune system. Immunol. Rev. 2005. 206: 149-159.
17. Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A. K. and Flavell, R. A., Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 2006. 24: 99-146.
18. Becker, C., Fantini, M. C., Schramm, C., Lehr, H. A., Wirtz, S., Nikolaev, A., Burg, J. et al., TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity 2004. 21: 491-501.
19. Souza, R. F., Garrigue-Antar, L., Lei, J., Yin, J., Appel, R., Vellucci, V. F., Zou, T. T. et al., Alterations of transforming growth factor-beta 1 receptor type II occur in ulcerative colitis-associated carcinomas, sporadic colorectal neoplasms, and esophageal carcinomas, but not in gastric neoplasms. Hum. Cell 1996. 9: 229-236.
20. Souza, R. F., Lei, J., Yin, J., Appel, R., Zou, T. T., Zhou, X., Wang, S. et al., A transforming growth factor beta 1 receptor type II mutation in ulcerative colitis-associated neoplasms. Gastroenterology 1997. 112: 40-45.
21. Beck, P. L., Rosenberg, I. M., Xavier, R. J., Koh, T., Wong, J. F. and Podolsky, D. K., Transforming growth factor-beta mediates intestinal healing and susceptibility to injury in vitro and in vivo through epithelial cells. Am. J. Pathol. 2003. 162: 597-608.
22. + regulatory T cells. J. Exp. Med. 2005. 201: 737-746.
23. Kobori, A., Yagi, Y., Imaeda, H., Ban, H., Bamba, S., Tsujikawa, T., Saito, Y. et al., Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. J. Gastroenterol. 2010. 45: 999-1000.
24. Seidelin, J. B., Bjerrum, J. T., Coskun, M., Widjaya, B., Vainer, B. and Nielsen, O. H., IL-33 is upregulated in colonocytes of ulcerative colitis. Immunol. Lett. 2010. 128: 80-85.
25. Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G. et al., IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005. 23: 479-490.
26. Lang, R., Rutschman, R. L., Greaves, D. R. and Murray, P. J., Autocrine deactivation of macrophages in transgenic mice constitutively overexpressing IL-10 under control of the human CD68 promoter. J. Immunol. 2002. 168: 3402-3411.
27. Gough, P. J., Gordon, S. and Greaves, D. R., The use of human CD68 transcriptional regulatory sequences to direct high-level expression of class A scavenger receptor in macrophages in vitro and in vivo. Immunology 2001. 103: 351-361.
28. Lee, G. T., Hong, J. H., Kwak, C., Woo, J., Liu, V., Lee, C. and Kim, I. Y., Effect of dominant negative transforming growth factor-beta receptor type II on cytotoxic activity of RAW 264.7, a murine macrophage cell line. Cancer Res. 2007. 67: 6717-6724.
29. Hahm, K. B., Im, Y. H., Parks, T. W., Park, S. H., Markowitz, S., Jung, H. Y., Green, J. and Kim, S. J., Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut 2001. 49: 190-198.
30. Ince, M. N., Elliott, D. E., Setiawan, T., Metwali, A., Blum, A., Chen, H. L., Urban, J. F. et al., Role of T cell TGF-β signaling in intestinal cytokine responses and helminthic immune modulation. Eur. J. Immunol. 2009. 39: 1870-1878.
31. Frugier, T., Koishi, K., Matthaei, K. I. and McLennan, I. S., Transgenic mice carrying a tetracycline-inducible, truncated transforming growth factor beta receptor (TGF-βRII). Genesis 2005. 42: 1-5.
32. Kang, S. S., Bloom, S. M., Norian, L. A., Geske, M. J., Flavell, R. A., Stappenbeck, T. S. and Allen, P. M., An antibiotic-responsive mouse model of fulminant ulcerative colitis. PLoS Med. 2008. 5: e41.
33. Chanteux, H., Guisset, A. C., Pilette, C. and Sibille, Y., LPS induces IL-10 production by human alveolar macrophages via MAPKinases- and Sp1-dependent mechanisms. Respir. Res. 2007. 8: 71.
34. Maeda, H., Kuwahara, H., Ichimura, Y., Ohtsuki, M., Kurakata, S. and Shiraishi, A., TGF-β enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice. J. Immunol. 1995. 155: 4926-4932.
35. H17 cell differentiation by antagonizing RORγt function. Nature 2008. 453: 236-240.
36. Kriegel, M. A., Li, M. O., Sanjabi, S., Wan, Y. Y. and Flavell, R. A., Transforming growth factor-beta: recent advances on its role in immune tolerance. Curr. Rheumatol. Rep. 2006. 8: 138-144.
37. Lang, R., Patel, D., Morris, J. J., Rutschman, R. L. and Murray, P. J., Shaping gene expression in activated and resting primary macrophages by IL-10. J. Immunol. 2002. 169: 2253-2263.
38. Greaves, D. R. and Gordon, S., Macrophage-specific gene expression: current paradigms and future challenges. Int. J. Hematol. 2002. 76: 6-15.
39. Herbert, D. R., Holscher, C., Mohrs, M., Arendse, B., Schwegmann, A., Radwanska, M., Leeto, M. et al., Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 2004. 20: 623-635.
40. Sasmono, R. T., Oceandy, D., Pollard, J. W., Tong, W., Pavli, P., Wainwright, B. J., Ostrowski, M. C. et al., A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood 2003. 101: 1155-1163.
41. Buanne, P., Di Carlo, E., Caputi, L., Brandolini, L., Mosca, M., Cattani, F., Pellegrini, L. et al., Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice. J. Leukoc. Biol. 2007. 82: 1239-1246.
42. Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S. and Albelda, S. M., Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 2009. 16: 183-194.
43. Lin, A. A., Tripathi, P. K., Sholl, A., Jordan, M. B. and Hildeman, D. A., Gamma interferon signaling in macrophage lineage cells regulates central nervous system inflammation and chemokine production. J. Virol. 2009. 83: 8604-8615.
44. Lykens, J. E., Terrell, C. E., Zoller, E. E., Divanovic, S., Trompette, A., Karp, C. L., Aliberti, J. et al., Mice with a selective impairment of IFN-γ signaling in macrophage lineage cells demonstrate the critical role of IFN-γ-activated macrophages for the control of protozoan parasitic infections in vivo. J. Immunol. 2010, 184: 877-885.
45. H1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999. 10: 39-49.
46. Murray, P. J., The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. Proc. Natl. Acad. Sci. USA 2005. 102: 8686-8691.
47. Ahrens, R., Waddell, A., Seidu, L., Blanchard, C., Carey, R., Forbes, E., Lampinen, M. et al., Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis. J. Immunol. 2008. 181: 7390-7399.
48. Munitz, A., Waddell, A., Seidu, L., Cole, E. T., Ahrens, R., Hogan, S. P. and Rothenberg, M. E., Resistin-like molecule alpha enhances myeloid cell activation and promotes colitis. J. Allergy Clin. Immunol. 2008. 122: 1200-1207 e1201.
49. Fuss, I. J., Boirivant, M., Lacy, B. and Strober, W., The interrelated roles of TGF-β and IL-10 in the regulation of experimental colitis. J. Immunol. 2002. 168: 900-908.
50. Denning, T. L., Wang, Y. C., Patel, S. R., Williams, I. R. and Pulendran, B., Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat. Immunol. 2007. 8: 1086-1094.
51. Pastorelli, L., Garg, R. R., Hoang, S. B., Spina, L., Mattioli, B., Scarpa, M., Fiocchi, C. et al., Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis. Proc. Natl. Acad. Sci. USA 2010. 107: 8017-8022.
52. Beltran, C. J., Nunez, L. E., Diaz-Jimenez, D., Farfan, N., Candia, E., Heine, C., Lopez, F. et al., Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 2010. 16: 1097-1107.
53. Fuss, I. J., Heller, F., Boirivant, M., Leon, F., Yoshida, M., Fichtner-Feigl, S., Yang, Z. et al., Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J. Clin. Invest. 2004. 113: 1490-1497.
54. Leppkes, M., Becker, C., Ivanov, II., Hirth, S., Wirtz, S., Neufert, C., Pouly, S. et al., RORγ-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 2009. 136: 257-267.
55. Oboki, K., Ohno, T., Kajiwara, N., Arae, K., Morita, H., Ishii, A., Nambu, A. et al., IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc. Natl. Acad. Sci. USA 2010. 107: 18581-18586.
56. Shah, A. H., Tabayoyong, W. B., Kimm, S. Y., Kim, S. J., Van Parijs, L. and Lee, C., Reconstitution of lethally irradiated adult mice with dominant negative TGF-β type II receptor-transduced bone marrow leads to myeloid expansion and inflammatory disease. J. Immunol. 2002. 169: 3485-3491.